All patients treated in proof of concept study in women with bacterial vaginosis

All patients treated in Swedish women’s health company Gedea Biotech’s pHyph proof of concept study in women with bacterial vaginosis Lund, Sweden, October 31, 2019. Gedea Biotech, an innovative women’s health company today reports that all 24 patients have been treated with its lead product,…


Gedea Biotech AB
Medicon Village
Scheeletorget 1
223 81 Lund
Sweden

Annette Säfholm, CEO
annette.safholm@gedeabiotech.com
+46 (0) 708 – 91 86 81